Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers

• Päätekijät: Yingzi Cui (Tekijä), Dongyang Cui (Tekijä), Xinran Ren (Tekijä), Xuesong Chen (Tekijä), Guangwen Liu (Tekijä), Zhengzhi Liu (Tekijä), Yanli Wang (Tekijä), Xinyao Qu (Tekijä), Yicheng Zhao (Tekijä), Haimiao Yang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objectives: Pertuzumab is a monoclonal antibody for the treatment of breast cancer. The aim of this study was to compare the pharmacokinetics, immunogenicity and safety of the test preparation SHR-1309 injecta and the reference preparation Perjeta® in healthy Chinese male subjects.Methods: In this r...